Tuesday, August 30, 2016

BRIEF-FDA accepts Mitsubishi Tanabe Pharma's NDA filing for Edaravone to treat ALS

* FDA accepts Mitsubishi Tanabe Pharma's NDA filing for

Edaravone to treat ALS

Read more

No comments:

Post a Comment